Skip to main content
Equibles

Swiss National Bank

Bank

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1582202 ZURICH, V8
Back to BBIO Full portfolio

Position in BBIO

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$21,941,808
+$703,448 QoQ
Shares Held
294,600
+3.0% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 472 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. BBIO ranks #14 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in BBIO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,941,808 294,600
2026-03-31 $21,238,360 286,000
2025-12-31 $21,616,074 282,600
2025-09-30 $14,335,440 276,000
2025-06-30 $10,984,992 254,400
2025-03-31 $8,227,660 238,000
2024-12-31 $6,593,832 240,300
2024-09-30 $5,583,378 219,300
2024-06-30 $5,494,077 216,900
2024-03-31 $6,369,520 206,000
2023-12-31 $7,109,157 176,100
2023-09-30 $5,118,417 194,100
2023-06-30 $3,298,960 191,800
2023-03-31 $2,407,416 145,200
2022-12-31 $1,227,582 161,100
2022-09-30 $1,555,610 156,500
2022-06-30 $1,421,020 156,500
2022-03-31 $1,412,880 139,200
2021-12-31 $2,476,980 148,500
2021-09-30 $6,960,195 148,500
2021-06-30 $9,003,792 147,700
2021-03-31 $7,348,880 119,300